Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?
Related Questions
What is your treatment approach for MAG antibody associated polyneuropathy?
What is your approach to managing seronegative myasthenia gravis in patients who have not responded to immunotherapy?
How do you counsel patients on the benefits of immunotherapy for anti-MAG neuropathy?
How do you decide if patients who have a multifocal demyelinating polyneuropathy would benefit from surgical treatment of carpal tunnel syndrome?
Do you routinely perform muscle biopsies in patients presenting with the classic symptoms of Inclusion Body Myositis along with positive CN1A antibody?
How do you use serum IgG levels when treating with FcRN inhibitors?
What is your approach to patients with diffuse, patchy paresthesias affecting the head, face, lips, and/or tongue?
When and how do you perform genetic testing for congenital myasthenia gravis in seronegative cases?
When do you consider testing autoimmune antibodies for axonal polyneuropathies without clear etiology?
Which methods of tracking response to treatment in myasthenia gravis do you find most helpful?
